CJG, it is useful at this point to recall that Reuters article in the last month or so reported that Bayer's Nexavar failed its Phase III trial in liver cancer---I believe I posted that article here or on Dew's BTValue board with an introduction like"Looks like Bayer[Nexavar] can use a little help in liver cancer indication"
News 
Market Data 
Discover 
AI
